Atenolol Press Coated (HE) Tablet
|
|
- Derick Harris
- 5 years ago
- Views:
Transcription
1 CHAPTER 6: FORMULATION AND EVALUATION OF ATENOLOL PULSATILE PRESS COATED TABLETS USING RUPTURABLE AND ERODIBLE POLYMERS 6.1. INTRODUCTION AND AIM OF THE STUDY In order to achieve the chronopharmaceutical design for the time controlled pulsatile type of colon targeted preparations, formulation design to control the lag time is prior to the immediate release of drug. These systems have a peculiar mechanism of delivering the drug rapidly and completely after a lag time (a period of no drug release). Though most delivery systems are designed for constant drug release over a prolong period of time, pulsatile delivery systems are characterized by a programmed drug release, as constant blood levels of a drug may not always be desirable. Pulsatile time release systems are designed in a manner that the drug is available at the site of action at the right time in the right amount. These systems are beneficial for drugs having high first pass effect, drugs administered for diseases that follow chronological behavior, drugs having specific absorption site in GIT, targeting to colon, where night time dosing is required (Sadaphal et al., 2011). Atenolol, a β-blocker, is prescribed widely in diverse cardiovascular diseases like; Hypertension, angina pectoris, arrhythmias, and myocardial infarction. In case of cardiovascular diseases, several functions (e.g. BP, heart rate, stroke volume, cardiac output, blood flow) of the cardiovascular system are subject to circadian rhythms. It has been reported that more shocks and heart attacks occur during morning hours (Shweta et al., 2008). The level of cortisol is higher in the morning hours, and its release is reported to decline gradually during the day. Blood pressure is also reported to be high in the morning till late afternoon, and then drops off during night (Lemmer, 1999). On oral administration of colon targeted pulsatile drug delivery system at bed time, releases atenolol after a desired lag time of about hr which corresponds with peak levels of cortisol, capillary resistance, platelet agreeability and vascular reactivity in the morning hours, which leads to hypertension in the early hours of the morning. Rajesh A. Keraliya 129
2 After oral administration, press coated tablets undergo transit from the stomach to the cecum or colon. Despite widespread use of ph dependent systems for colon targeted delivery of drugs, there has always been a controversy about their usefulness for the intended purpose, mainly because of high ph variability of the gastrointestinal tract between and within individuals and lack of proper coating materials that would dissolve at the desired ph of the colon. It is affected by diet and disease. During acute stage of inflammatory bowel disease colonic ph has been found to be significantly lower than normal. In ulcerative colitis ph values have been measured in the proximal parts of the colon (Ashish et al., 2009). This disadvantage was overcome by developing time dependent rupturable and erodible type press coated pulsatile colon targeted drug delivery using combination of hydrophilic and hydrophobic polymer. Hydroxypropylmethylcellulose (HPMC) is a well known water-soluble polymer that has long been used as a rate-controlling membrane in medication dosage forms to regulate drug release. HPMC has an ability to swell upon gellification once in contact with water. The gel becomes a viscous layer around a core, acting as a protective barrier to both the influx of water and the efflux of the drug in solution (Kiil and Dam, 2003). HPMC K4M has a swelling, viscous property of gelation and an erosion property which might delay the drug release because of lengthening of the drug diffusion pathway and drug release rate. This hydrophilic polymer is responsible for rupturing the outer coat (Andrea et al., 2008). Hydrophilic polymer (HPMC K4M) alone for controlling the drug release of highly water soluble drugs like atenolol is restricted due to rapid diffusion of the dissolved drug through the hydrophilic gel layer (Lin et al., 2004). Use of hydrophobic polymers such as Ethyl cellulose with HPMC K4M will retard the drug release. So, in the present investigation, an attempt has been to formulate time controlled pulsatile release tablets of atenolol using hydrophilic polymer (HPMC K4M) in combination with hydrophobic polymer (EC). Ethylcellulose (EC) is a semipermeable in nature, although it is naturally insoluble in water, has been used as a rate-controlling membrane to regulate drug release. EC has been directly compressed to form compact film in which plastic deformation is the predominant consolidation mechanism (Liberman et al., 1990). Ethyl cellulose exhibiting a porous structure, it controls the diffusion of the water inside the coating layer of HPMC K4M, kept integrity of sweallbale layer of HPMC K4M and the Rajesh A. Keraliya 130
3 retard the drug release. When the barrier layer containing HPMC K4M along with ethyl cellulose was exposed to dissolution media, the HPMC K4M particles swell and erode which is responsible for breakdown of outer coating, a process which was retarded to varying degrees depending upon the quantity of EC present, demonstrating that manipulation of both components controls the erosion rate (Rubinstein et al., 1997). The purpose of this study was to develop press coated tablets for pulsatile drug delivery of atenolol by achieving the ph independent time-controlled disintegrating or rupturing function with a distinct predetermined lag time. The rapidly disintegrating inner core tablets containing atenolol and other excipients were compression coated by a barrier layer consisting of mixture of different weight ratios of hydrophobic polymer (ethylcellulose) and hydrophilic polymers (HPMC K4M) to avoid drug release in gastric and intestinal fluids. Ethyl cellulose was chosen because of its rupturable behavior and HPMC K4M was chosen because of its swelling and erodible behavior PREPARATION OF ATENOLOL CORE (AT2) TABLETS The core tablets of atenolol (AT2) were prepared by direct compression method. An optimized core tablet was formulated using various concentrations of dry binder and super disintegrant as describe in table 21. An accurately weighed quantity of atenolol, microcrystalline cellulose, polyvinyl pyrroloide (PVP K30) and sodium starch glycolate pass through 40# and mix in double cone blender for 15 min. Add talc (2% w/w) (40#) into blend and mix in double cone blender for 10 min. Add magnesium stearate (1% w/w) (40#) into blend and mix in double cone blender for 5 min. The resultant powder mixtures were compressed into tablets (average tablet weight = 80 mg) by 6 mm standard concave plain punches using rotary tabletting machine (Hardik Engineering Works, Ahmedabad, India). The prepared atenolol core tablets were tested for weight variation, hardness, thickness, drug content, disintegration time, friability and in vitro dissolution study (Sawada et al., 2003, Mayur et al., 2009, Gang et al., 2004) PREPARATION OF ATENOLOL PRESS COATED (HE) TABLETS The core tablets were compression coated with 150 mg of coating material containing different weight ratios of HPMC K4M and EC. The weight ratios of HPMC K4M and EC Rajesh A. Keraliya 131
4 were used for the compression coating shown in table 22. Weigh accurately 150 mg of coating material, add talc (2% w/w) (40#) into it and mix in double cone blender for 10 min. Add magnesium stearate (1% w/w) (40#) into blend and mix in double cone blender for 5 min. 43 % of (64.5 mg) weight of coating material was first placed into die cavity (diameter 9 mm). Then, the core tablet was carefully placed on it manually at the centre of the die. The remaining 57 % of (85.5 mg) of the coating materiel was added into the die and the coating material was then compressed around the core tablet by 9 mm standard concave plain punches using rotary tabletting machine (Cadmach Machinery, Ahmedabad, India). The prepared compression coated atenolol tablets were tested for weight variation, hardness, thickness, drug content, friability and in vitro dissolution study (Chickpetty et al., 2010, Soad et al., 2009, Krishnaiah et al., 2003). Table 21: Composition of atenolol core (AT2) tablet Ingredients Quantity for each tablet (mg) Atenolol (API) 45 mg Sodium Starch Glycolate (SSG) (5%) 4 mg Polyvinyl pyrollidone K30 (PVP K30) (5%) 4 mg Microcrystalline Cellulose (MCC) 24.6 mg Talc (2%) 1.6 mg Mg Stearate (1%) 0.8 mg Total Weight 80 mg Table 22: Formulations of atenolol press coated (HE) tablets Formulation code Core tablet HPMC K4M : EC ratio (mg) HE1 A2 150 : 00 HE2 A2 125 : 25 HE3 A2 100 : 50 HE4 A2 75 : 75 HE5 A2 50 : 100 HE6 A2 25 : 125 HE7 A2 00 : 150 Rajesh A. Keraliya 132
5 6.4. EVALUATION OF ATENOLOL CORE (AT2) AND PRESS COATED (HE) TABLETS Spectrophotometric estimation of atenolol Atenolol was estimated by UV visible spectroscopy. Spectrophotometric estimation of atenolol was carried out in methanol, 0.1 N HCl, phosphate buffer ph 6.8 and phosphate buffer ph 7.4. Detail procedures and results of spectrophotometric estimation of atenolol in methanol and phosphate buffer ph 7.4 were discussed in chapter 5 on page no. 110 and The study was carried out in triplicates. Preparation of standard stock solution in 0.1 N HCl and phosphate buffer ph 6.8 Accurately weighed 100 mg of atenolol was placed in 100 ml volumetric flask and dissolved in 100 ml of 0.1 N HCl and phosphate buffer ph 6.8. From this solution, 10 ml solution was withdrawn and further diluted to 100 ml with 0.1 N HCl and phosphate buffer ph 6.8 to yield the standard stock solution of atenolol (100 µg/ml). Construction of calibration curve in 0.1 N HCl and phosphate buffer ph 6.8 From the stock solution, 5, 10, 15, 20, 25 and 30 ml were withdrawn and diluted to 100 ml with 0.1 N HCl to yield concentration of 5, 10, 15, 20, 25 and 30 g/ml respectively. For phosphate buffer ph 6.8, 2.5, 5, 10, 15, 20, 25, 30 and 35 ml of stock solution were withdrawn and dilute to 100 ml with phosphate buffer ph 6.8 to yield concentration of 5, 10, 15, 20, 25 and 30 g/ml respectively. Absorbance of each solution was measured at 225 nm using UV visible spectrophotometer (Thermo Scientific Evolution 201). Samples were analyzed in triplicate and the average values were used for plotting the graph of absorbance versus concentration ( g/ml). Regression analysis was done on each beer s plot using Microsoft excel Drug-Excipient compatibility study The compatibility of drug with polymeric excipients of press coated tablets was performed using Fourier transform infrared spectroscopy and Differential Scanning Calorimetry (DSC). Procedure followed to obtain FTIR spectra and DSC thermographs of pure sample powder of atenolol and powder of atenolol core tablet is discussed in chapter 5 on page no Rajesh A. Keraliya 133
6 Evaluation of flow property of powder blends Powder blends used for preparation of atenolol core tablets and compression coated tablets were evaluated for flow property by measuring bulk density, tapped density, carr s index, hausner s ratio and angle of repose. Detailed procedure adopted for evaluation of flow property was discussed in chapter 5 on page no Post compression evaluation of atenolol core (AT2) and press coated (HE) tablets Weight Variation Twenty tablets from each batch were individually weighed using electronic digital balance (Shimadzu BL 220 H) and average weight was calculated. Individual weights of the tablets were compared with the average weight according to the official method in Indian Pharmacopoeia, 2007 (Fukui et al., 2000, Gazzaniga et al., 1994). Hardness Six tablets from each batch were selected and tested for tablet hardness using Monsanto hardness tester. The tablet was placed in contact between the plungers and the handle was pressed, the force of the fracture that causes the tablet to break was recorded. Thickness The thickness of ten tablets from each batch was determined using vernier calipers as per Indian Pharmacopoeia, 2007 (Madhusudan and Vishal, 2001). Friability The friability of the twenty tablets from each batch was determined using Roche friabilator (Indosati Scientific Lab. Equipments) (Mastiholimath et al., 2007, Matsuo et al., 1995). This device subjects the tablets to the combined effect of abrasions and shock in a plastic chamber revolving at 25 rpm and dropping the tablets at a height of 6 inches in each revolution. A pre-weighed sample (20 tablets) was placed in the friabilator and is subjected to 100 revolutions. Tablets were dedusted and reweighed. The % friability (F) was calculated using following formula: F = (W1-W2 / W1) (10) Rajesh A. Keraliya 134
7 Where, W1 is the initial weight of the sample of twenty tablets before the test W2 is the weight of the tablet after the test Drug content For determination of drug content, ten tablets were crushed into powder and powder equivalent to 45 mg of atenolol was weighed and dissolved in methanol then filtered through syringe filter (Axiva SFCA25X, 0.45µm). Solution was analyzed for Atenolol content by spectrophotometrically by UV spectrophotometer (Thermo Scientific Evolution 201) at wavelength of 225 nm using methanol as blank (Swati et al., 2010). Swelling studies One tablet from each press coated formulation was randomly selected, weighed individually (W1) and placed separately in petridishes containing 20 ml of phosphate buffer ph 7.4. After 6 h, the tablets were carefully removed from petridishes and excess water was removed using filter paper. The swollen tablets were reweighed (W2) and swelling index of each tablet was calculated using the equation 11 and expressed in percentage (Yeole et al., 2006, Prabhakara et al., 2010). Swelling index = (W2 W1)/ W1 *100 (11) Position of Core Tablet Compression coated tablet is cut vertically and cross sectional photographs were taken to evaluate the position of core tablet in the compression coated tablet (Reddy et al., 2010). In vitro drug release study of atenolol press-coated tablets In vitro drug release studies were carried out using USP Type II dissolution apparatus (Electrolab, TDT-08L) in a 900 ml of dissolution media at a temperature of 37±1 0 C at 100 rpm. In order to simulate the ph changes along the GI tract, multimedia dissolution studies were performed. Three dissolution media with ph 1.2, 6.8 and 7.4 were sequentially used. Initially dissolution study was performed using 0.1 N HCl (ph 1.2) as dissolution medium for 2 hrs (since the average gastric emptying time is 2 hrs), than dissolution medium was discarded and replaced with phosphate buffer ph 6.8 and dissolution study was continued for next 3 hrs (average small intestinal transit time is 3 Rajesh A. Keraliya 135
8 hrs). After 3 hrs, the dissolution medium was removed and replaced with phosphate buffer ph 7.4 for subsequent hours. At regular time intervals, 10 ml of sample was withdrawn and same amount replaced by fresh medium. Samples were suitably diluted and filtered through syringe filter (Axiva SFCA25X, 0.45µm). Drug amount released was analyzed spectrophotometrically by UV spectrophotometer (Thermo Scientific Evolution 201) at wavelength of 225 nm. All studies were carried out in triplicates (Swati et al., 2010, Sungthongjeen et al., 2004). The time for which the tablet does not show any release of the drug is known as its lag time. The lag time can be estimated through the dissolution profile of the tablet. The study was carried out in triplicates Stability study The optimized formulations of atenolol press coated tablets were subjected for accelerated stability studies according to ICH guidelines (40 ± 2 0 C and 75 ± 5% RH) for a period of 6 months in a stability chamber. The optimized formulations of atenolol press coated tablets were placed in vials and hermetically closed with bromobutyl rubber plugs, sealed with aluminum caps and placed in stability chamber. The samples were withdrawn at initial, 1 month, 2 months, 3 months and 6 months to evaluate for the drug content, hardness, and in vitro dissolution. The study was carried out in triplicates RESULT AND DISCUSSION Spectrophotometric estimation of atenolol Spectrophotometric estimation of Atenolol in 0.1 N HCl Table 23: Spectrophotometric analysis of atenolol in 0.1 N HCl Conc. Absorbance Average Standard (µg/ml) Set 1 Set 2 Set 3 Absorbance Deviation Rajesh A. Keraliya 136
9 Average Abs. Ph.D Thesis Atenolol exhibited its maximum absorption at 225 nm and obeyed Beer s law in the range of 5-30 μg/ml. Linear regression of absorbance on concentration gave equation y = 0.027x with a correlation coefficient of So, calibration curve of atenolol in methanol showed in figure 39 was linear in concentration range of 5-30 μg/ml. Calibration curve of atenolol in 0.1 N HCl y = x R² = Conc. (µg/ml) Figure 39: Calibration curve of atenolol in 0.1 N HCl Figure 40: Spectrophotometric images showing λmax of atenolol in 0.1 N HCl Rajesh A. Keraliya 137
10 Spectrophotometric estimation of Atenolol in phosphate buffer ph 6.8 Table 24: Spectrophotometric analysis of atenolol in phosphate buffer ph 6.8 Conc. Absorbance Average Standard (µg/ml) Set 1 Set 2 Set 3 Absorbance Deviation Calibration curve of atenolol in Phosphate Buffer ph 6.8 Average Abs y = 0.03x R² = Conc. (µg/ml) Figure 41: Calibration curve of atenolol in phosphate buffer ph 6.8 Atenolol exhibited its maximum absorption at 225 nm and obeyed Beer s law in the range of 5-30 μg/ml. Linear regression of absorbance on concentration gave equation y = 0.03x with a correlation coefficient of So, calibration curve of atenolol in methanol showed in figure 41 was linear in concentration range of 5-30 μg/ml. Rajesh A. Keraliya 138
11 Figure 42: Spectrophotometric images showing λmax and overlay spectra of atenolol in phosphate buffer ph Drug-Excipient compatibility study Fourier transform infrared spectroscopy Fourier transform infrared spectroscopy was used to analyze of pure sample powder of atenolol and powder of atenolol press coated tablet (HE). Figure 43 showed that FTIR spectras of all samples were identical and the main absorption bands of atenolol appeared in all the spectra. Absorption band for N-H stretching of CO-NH2 group of atenolol appeared around 3340 and 3160 cm 1 in the both spectra. The absorption band for -C=O (amide I) and N-C=O (amide II) stretching of atenolol located at 1625 cm 1 and 1500 cm 1 in spectra of pure atenolol drug powder, and these were also appear and not shifted in the FTIR spectra of powder of atenolol press coated tablet (HE). All spectra showed =C-H stretching of alkane group of atenolol around 2940 cm 1. Similarly, the H2N-C=O stretching of atenolol located at 1400 cm 1 was appeared both in both spectra. Isopropyl group of atenolol showed a sharp peak in all spectra around 1385 cm 1 and 1170 cm 1. Arylether of atenolol structure give the peak at 1390 cm 1 and 1235 cm 1 in spectra of pure atenolol drug powder, and these were also appear in the FTIR spectra of powder of atenolol press coated tablet (HE) (Klaus et al., 2005). The FTIR spectra of the tested Rajesh A. Keraliya 139
12 samples showed the prominent characterizing peaks of pure atenolol which confirmed that no chemical modification of the drug had been taken place and indicated that there is no chemical interaction occurred between drug and excipients at the molecular level. Figure 43: FTIR spectra of: pure sample powder of atenolol (A) and powder of atenolol press coated (HE) tablet (B) Differential Scanning Calorimetry (DSC) The DSC results of pure sample powder of atenolol and powder of atenolol press coated tablet showed in figure 44. DSC thermographs of pure sample powder of atenolol and powder of atenolol press coated tablet showed a sharp exothermic peak (Tm) at C and C respectively, which corresponding to melting point of atenolol (154 C to 156 C) (Klaus et al., 2005, Gurpreet et al., 2009). Melting exotherm not appreciably change in powder of atenolol press coated tablet as compared to atenolol pure sample. This observation confirmed the absence of chemical interaction of drug with excipients of press coated tablet, further supporting the results of IR spectroscopy. Rajesh A. Keraliya 140
13 Figure 44: DSC thermographs of: pure sample powder of atenolol (A) and powder of atenolol press coated (HE) tablet (B) Flow property study of powder blend The bulk density, tapped density, angle of repose, hausner s ratio and carr s index of powder blend for atenolol core tablets are ± 0.03, 0.33 ± 0.04, O ± 0.40, ± 0.12 and ± 0.65 respectively as shown in table 25. The results of indicated that powder blend has good flow property with good compressibility and suitable for direct compression method. The angle of repose, hausner s ratio and carr s index of powder blend used for coating of core tablets were ranged from O ± 0.95 to O ± 0.5, ± 0.05 to ± 0.08, and ± 0.69 % to15.89 ± 0.44% respectively as shown in table 25. The values of pre-compression parameters evaluated were within prescribed limit and indicated a good free flowing property and suitable for direct compression method. Rajesh A. Keraliya 141
14 Table 25: Flow property study for powder blend of atenolol core (AT2) and press coated (HE) tablets Formulation Code Bulk Density (g/cm 3 ) Tapped Density (g/cm 3 ) Carr s Index (%) Hausner s Ratio (HR) Angle of Repose (Ɵ) A ± ± ± ± O ± 0.40 HE ± ± ± ± O ± 0.5 HE ± ± ± ± O ± 0.75 HE ± ± ± ± O ± 1.05 HE ± ± ± ± O ± 0.45 HE ± ± ± ± O ± 0.60 HE ± ± ± ± O ± 0.85 HE ± ± ± ± O ± Post compression study of core tablets and press coated tablets The data obtained from post-compression study of core and press coated tablets such as weight variation, hardness, friability, and drug content are shown in table 26. The hardness of core tablets of atenolol was 3.25 ± 0.15, indicated that core tablets had good crushing strength. The friability, drug content, weight variation and thickness of atenolol core tablets were 0.12 ± 0.05 %, ± 1.3 %, ± 2.57 and 3.20 ± 0.05 respectively, which indicate that atenolol core tablets passed the post compression study. In all press coated formulations, the hardness test indicated good mechanical strength. Hardness was ranged from 6.0 to 7.5 Kg/cm 2. Friability was ranged from 0.08 ± 0.08 to 0.15 ± Friability is less than 1% which indicated that tablets had good mechanical resistance. Drug content was found to be high (>99.45 %). It was ranged from ±1.3 to ± 1.4 % and uniform in all tablet formulations. In weight variation test, 20 tablets were selected random and average weight variation was calculated. Then individual tablet were weighed and weight was compared with average weight. It was varied from ± 1.90 to ± 2.30 mg. None of tablets showed more than 7.5 % weight variation from average weight. So, all formulations pass the weight variation test as per IP. Tablet thickness varied from 4.9 to 5.1 mm. Rajesh A. Keraliya 142
15 Table 26: Post-compression parameters of atenolol core (AT2) and press coated (HE) tablets Formulation Code Hardness (Kg/cm 2 ) Friability (%) Drug content (%) Weight variation (mg) Tablet Thickness (mm) AT ± ± ± ± ± 0.05 HE1 7.5 ± ± ± ± ± 0.05 HE2 7.0 ± ± ± ± ± 0.02 HE3 6.5 ± ± ± ± ± 0.05 HE4 6.5 ± ± ± ± ± 0.02 HE5 6.0 ± ± ± ± ± 0.02 HE6 6.0 ± ± ± ± ± 0.05 HE7 6.0 ± ± ± ± ± 0.05 Position of Core Tablet Cross sectional photograph in figure 45 of atenolol compression coated tablet showed that atenolol core tablet centrally placed into compression coated tablet. Figure 45: Cross sectional photographs of atenolol press coated (HE) tablet % Swelling study Swelling study of press coated tablets indicated that, combination of EC and HPMC K4M, when used have better capacity to protect the drug from being released in the upper parts of the GIT than HPMC K4M alone compression coated tablets. This may be due to Rajesh A. Keraliya 143
16 HPMC K4M is being more hydrophilic as the swelling index is better for HPMC K4M. Table 27 describes the % swelling ratio of different batches of HE1 to HE7. As the amount of HPMC K4M increases swelling of tablet increases. HE1 batch having high amount of HPMC K4M (having HPMC K4M alone) was showed high ± 6.40 percentage of swelling. HPMC K4M alone released the drug relatively at a faster rate than combination of EC and HPMC K4M because it formed weak sweallable layer, which could rupture easily upon exposure to the dissolution medium. While HE7 batch having EC alone could not maintain the integrity, it divided into two equal halves and no sign of swelling. Batches HE2 to HE6 showed that as amount of EC is increased in the mixture of HPMC K4M and EC, % swelling of tablet decreases because of EC retard the swelling of HPMC K4M. It was also observed that throughout drug release study; combination of EC and HPMC K4M compression coated tablets (Formulation HE2 to HE6) released the drug at slower pace compared to HPMC K4M alone compression coated tablets (Formulation HE1), EC retard the retards hydration of HPMC K4M and maintain the integrity of swellable layer of HPMC K4M (Prabhakara et al., 2010). EC acts as a semipermeable membrane, controls the passage of water inside the core, core swells and ruptures the EC coat. In vitro dissolution study of atenolol press coated tablets In time controlled press coated tablets, drug containing core compressed with the outer barrier layer, being outer barrier layer present, it prevents the rapid drug release from core tablets. The drug will not be released unless the coat is broken. When the dissolution medium reaches the core after eroding or rupturing the outer barrier layer rapid drug release was observed. The release profile of compression coated tablet exhibited lag time followed by burst release, in which outer shell break into two halves (Carla et al., 2007, Janugade et al., 2009). Release of drugs from the compression coated tablet follows three consecutive steps: 1. Penetration of dissolution media into the compressed coated tablet 2. Swelling or erosion of hydrophilic polymer 3. Breakdown of outer coating into two halves due to swelling or erosion of hydrophilic polymer used in coating Rajesh A. Keraliya 144
17 Dissolution profile showed in figure 46 produce a lag time prior to drug release due to incorporation of core tablet into press coated tablet. Press coated tablets (HE1 to HE7 formulations) showed distinct lag time as given table 27. When, HPMC K4M alone (HE1), showed lag time of only 04 hr. This is probably because of mechanism of producing a lag time of this formulation was based upon the hydration and swelling of outer barrier layer or water penetration through outer barrier layer (Ghimire et al., 2007). When HPMC K4M was used alone, it formed a mechanically weak sweallable layer, which could rupture easily upon exposure to the dissolution medium and resulting development of internal pressure within tablet core and drug release was initiated (Prashant et al., 2011). With Ethylcellulose alone (HE7), showed lowest lag time of two hours as compared to any weight ratio of mixture of HPMC K4M and EC. The porosity is proportional to the proportion of EC. Increase amount of EC leads to higher penetration of dissolution media in press coated tablet. EC is semipermeable in nature, although it is naturally insoluble in water. Water penetrates faster the coating layer of the core tablet when used alone. After hydration of core, the drug was released (Janugade et al., 2009). Table 27: Lag time and % swelling index of atenolol press coated (HE) tablets Formulation Code Lag Time (hr) % Swelling Index HE ± 6.40 HE ± 6.60 HE ± 7.50 HE ± 6.78 HE ± 5.07 HE ± 3.95 HE7 2 Divide into two equal halves When ethylcellulose was used in combination with HPMC K4M, it causes synchronization between swelling and erosion of the polymer in maintaining a constant stable gel layer for a long period of time (Prajapati et al., 2010). Upon contact with dissolution medium HPMC K4M hydrated and formed compact with ethylcellulose. The hydrophobicity of ethylcellulose retards the hydration of HPMC K4M. Therefore dissolution medium did not penetrate the outer coating layer, but the coating eroded Rajesh A. Keraliya 145
18 % Cumulative Drug Release Ph.D Thesis slowly. The active erosion rate of outer barrier layer depends upon the composition of the formulation which determines the lag time of press coated tablets (Prashant et al., 2011). Press coated tablets HE2-HE6 formulations showed distinct lag time as given in table 27. Obviously, the period of lag time was different and dependent on the weight ratio of mixture of HPMC K4M and EC. The combination of HPMC K4M and EC showed the synergistic effect on lag time. The finding indicates that the lag time of a press coated tablet can be modulated from 5.5 to 7.5 hrs by combining EC with HPMC K4M in different weight ratio. The system was found to be satisfactory in terms of release of the drug after a predetermined lag time of 6-7 hr and thus the dosage forms can be taken at bedtime, so, that the content will be released in the morning hours, i.e., at the time of symptoms. The release of drug was rapid and complete after the lag time. Lag time can be controlled by adjusting the mixture containing different weight ratio of HPMC K4M and EC. Results of drug release study of atenolol press coated tablets shown in table 28 stated that formulations HE4 and HE5 compression coated tablets achieve a burst release after 6.5 hr and 6 hr lag time respectively, which is applicable pulsatile drug delivery of atenolol for hypertension. 120 Dissolution profile of Atenolol Press Coated (HE) tablets HE1 HE2 HE3 HE4 HE5 HE6 HE Time (hrs) Figure 46: Dissolution profile of atenolol press coated (HE) tablets Rajesh A. Keraliya 146
19 Table 28: % Cumulative drug release study of atenolol press coated (HE) tablets Time % Cumulative Drug Release (hrs) HE1 HE2 HE3 HE4 HE5 HE6 HE ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± Stability study Table 29: Stability study of optimized atenolol press coated (HE5) tablets Tests Initial 1 month 2 months 3 months 6 months Drug content (%) ± ± ± ± ± 1.7 Hardness (kg/cm 2 ) 6.0 ± ± ± ± ± 0.75 Lag time (hr) The optimized HE5 batch of atenolol press coated tablets was subjected for accelerated stability studies according to ICH guidelines (40 ± 2 0 C and 75 ± 5% RH) for a period of 6 months in a stability chamber. Formulations did not show any significant changes in the drug content, hardness and in vitro dissolution during stability study as shown in table 29. Rajesh A. Keraliya 147
20 Hence, the HE5 atenolol press coated tablets were sufficiently stable as per regulatory requirements. CONCLUSION The promising colon targeted pulsatile type release of atenolol is successfully achieved by press coating technique using combination of time dependent rupturable and erodible polymers. Ethyl cellulose was chosen because of its rupturable behavior and HPMC K4M was chosen because of its swelling and erodible behavior. Atenolol press coated tablets were prepared using different weight ratios of HPMC K4M and EC. The formulations HE4 and HE5 were achieve a burst release after 6.5 hr and 6 hr lag time respectively, which is applicable pulsatile drug delivery of atenolol for treating early morning hypertension. Rajesh A. Keraliya 148
Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP
161 Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP 162 Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP S.No. Name of the Sub-Title Page No. 7.1. Optimization of formulations of Pulsincap
More informationCHAPTER-3 MATERIALS AND METHODS
75 CHAPTER-3 MATERIALS AND METHODS 76 3.1 MATERIALS 3.1.1 Drugs used in the present study Lamivudine Zidovudine Stavudine Drug name Source Alchem laboratories, Mumbai, India 3.1.2 Excipients and chemicals
More informationMouth Disintegrating Tablets of Taste-Masked Ondansetron HCl
Asian Journal of Chemistry Vol. 19, No. 5 (2007), 3455-3460 Mouth Disintegrating Tablets of Taste-Masked Ondansetron HCl V.K. CHATAP, D.K. SHARMA*, ANIL MIDDHA, R.D. GUPTA, VIPIN SAINI, MAHENDRA SHIRADKAR
More information8. FORMULATION OF LANSOPRAZOLE NANOPARTICLES
8. FORMULATION OF LANSOPRAZOLE NANOPARTICLES FORMULATION OF LANSOPRAZOLE NANOPARTICLES Preparation of capsule of modified solubility to protect the drug from degradation To protect the drug from degradation
More informationFormulation and evaluation of matrix tablets of Famotidine using hydrophilic polymer
Available online at www.scholarsresearchlibrary.com Scholars Research Library Archives of Applied Science Research, 2010, 2 (3):212-220 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-508X
More informationFormulation and in-vitro Evaluation of Captopril Floating Matrix Tablets Using HPMC 50cps
Formulation and in-vitro Evaluation of Captopril Floating Matrix Tablets Using HPMC 50cps Basawaraj S.Patil*, Sandeep J. Sonawane, Upendra Kulkarni, Hariprasanna R.C. PG Department of Pharmaceutics, R.M.E.S
More informationS.Janakidevi et al. Int. Res. J. Pharm. 2014, 5 (7) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article DESIGN AND OPTIMIZATION OF CEFIXIME TRIHYDRATE SUSTAINED RELEASE MATRIX TABLETS USING DIFFERENT POLYMERS S.Janakidevi*,
More informationIMPROVEMENT OF DISSOLUTION PROFILE OF LORNOXICAM BY SOLID DISPERSION USING SPRAY DRYING TECHNIQUE
66 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 3(5): September-October 2014 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET OF DILTIAZEM HYDROCHLORIDE BY MELT GRANULATION TECHNOLOGY
More informationResearch Article DESIGN AND EVALUATION OF SUSTAINED RELEASE FORMULATIONS OF THEOPHYLLINE USING NATURAL POLYMERS
International Journal of Research and Development in Pharmacy and Life Sciences Available online at http//www.ijrdpl.com October - November, 2013, Vol. 2, No.6, pp 721-725 ISSN: 2278-0238 Research Article
More informationDesign and In Vitro Characterization of Dexlansoprazole Controlled Release Tablets
ORIGINAL ARTICLE Design and In Vitro Characterization of Dexlansoprazole Controlled Release Tablets Y. Naveen Kumar 1, J. Sreekanth 2, P. Vijay Chander Reddy 3 1 Drugs Control Administration, Hyderabad,
More informationFORMULATION AND EVALUATION OF REPAGLINIDE FAST DISSOLVING TABLETS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF REPAGLINIDE FAST DISSOLVING TABLETS Chirravuri S Phani Kumar
More informationInternational Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Research Article CODEN: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com FORMULATION, OPTIMIZATION AND INVITRO EVALUATION OF
More informationDISSOLUTION PROFILLING OF NIMESULIDE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL, TALC AND THEIR COMBINATIONS AS DISPERSION CARRIERS
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.2, No.1, pp 480-484, Jan-Mar 2010 DISSOLUTION PROFILLING OF NIMESULIDE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL, TALC
More informationFormulation and Evaluation of Release-Retardant Matrix Tablets of Diclofenac Sodium
FABAD J. Pharm. Sci., 31, 119-16, 006 RESEARCH ARTICLE Formulation and Evaluation of Release-Retardant Matrix Tablets of Diclofenac Sodium Sunita DAHIYA*, Formulation and Evaluation of Release-Retardant
More informationCHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs
CHAPTER - 3 ANALYTICAL PROFILE 3.1 Estimation of Drug in Pharmaceutical Formulation 3.1.1 Estimation of Drugs ANALYTICAL PROFILE 84 3.1 ESTIMATION OF DRUG IN PHARMACEUTICAL FORMULATION. Agrawal A et al
More informationDEVELOPMENT AND VALIDATION OF A SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DRONEDARONE IN BULK DRUG AND PHARMACEUTICAL FORMULATION
Page186 Research Article Pharmaceutical Sciences DEVELOPMENT AND VALIDATION OF A SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DRONEDARONE IN BULK DRUG AND PHARMACEUTICAL FORMULATION Kishore Konam 1 &
More informationPreparation And Characterization Of Simvastatin Nanosuspension By Homogenization Method
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.1, pp 193-197, Jan-Mar 2013 Preparation And Characterization Of Simvastatin Nanosuspension By Homogenization Method
More informationResearch Article. Dissolution Study of Oxolamine Citrate by UV Spectrophotometric Method in Pharmaceutical Dosage Form
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(7):108-112 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Dissolution Study of Oxolamine Citrate by UV Spectrophotometric
More informationInternational Journal of Chemistry and Pharmaceutical Sciences. International Journal of Chemistry and Pharmaceutical Sciences
D. Nirmala Kumari et al, IJCPS, 2015, 3(5): 1678 1683 ISSN: 2321-3132 International Journal of Chemistry and Pharmaceutical Sciences Journal Home Page: www.pharmaresearchlibrary.com/ijcps Research Article
More informationFormulation and evaluation of sustained release matrix tablets of nifedipine
IJPAR Vol.4 Issue 3 Jul-Sep-2015 Journal Home page: ISSN: 2320-2831 Research article Open Access Formulation and evaluation of sustained release matrix tablets of nifedipine Eswar kumar.a 1*, A.Vaishnavi,
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com FORMULATION AND EVALUATION OF MONTLUKAST SODIUM EXTENDED RELEASE MATRIX TABLET 1 G.Rajini*, 2 Dr N. Srinivas Malla
More informationFormulation development and evaluation of sustained release matrix tablets of quetiapine fumarate
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(4):628-632 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Formulation development and evaluation of sustained
More informationImpact of Granulation and Effect of Polymers on Theophylline Release from Matrix Tablets
Impact of Granulation and Effect of Polymers on Theophylline Release from Matrix Tablets Kazi Rashidul Azam, Md. Shaikhul Millat Ibn Razzak, Ferdous Khan, Muhammad Shahidul Islam, Md. Ruknuzzaman Rony
More informationSpectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form
Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form Kailash P Prajapati *, A Bhandari INDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCES ISSN 2249-1023 Faculty of Pharmaceutical
More informationFormulation and evaluation of doxycycline hydrochloride delayed release enteric coated tablets
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2012, 4 (1): 249-255 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationFORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF GLICLAZIDE
ISSN 976 44X Research Article FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF GLICLAZIDE Ch.T.Lalitha kumari*, Dr.M.Mohan Varma, P.Satish Kumar, N. Jahnavi Shri Vishnu College of Pharmacy, Vishnupur,
More informationAREA UNDER CURVE AND SECOND ORDER DERIVATIVE SPECTROSCOPY OF METAXALONE IN BULK DRUG AND TABLET FORMULATION
Int. J. Chem. Sci.: 8(2), 2010, 823-827 AREA UNDER CURVE AND SECND RDER DERIVATIVE SPECTRSCPY F METAXALNE IN BULK DRUG AND TABLET FRMULATIN J. PRIYADHARISINI, G. P. GIGI, V. NIRAIMATHI and A. JERAD SURESH
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE FORMULATION AND EVALUATION OF SUSTAINED RELEASE PELLETS OF BOSENTAN HCl SIDDHI V. PATEL 1,2, DR. MUKESH S. PATEL 2 1. Research scholar,
More informationInternational Journal of Pharma and Bio Sciences
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE PHARMACEUTICAL ANALYSIS DEVELOPMENT, ESTIMATION AND VALIDATION OF BOSENTAN IN BULK AND IN ITS PHARMACEUTICAL FORMULATION BY UV-VIS SPECTROSCOPIC
More informationResearch Article. Development of Controlled Release Tablets of Nisoldipine with Improved Pharmaceutical Properties
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2013, 5(7):112-120 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development of Controlled Release Tablets of Nisoldipine
More informationInternational Journal of Current Trends in Pharmaceutical Research. International Journal of Current Trends in Pharmaceutical Research
G. Archana et al, IJCTPR, 2016, 4(2): 91 99 CODEN (USA): IJCTGM ISSN: 2321-3760 International Journal of Current Trends in Pharmaceutical Research Journal Home Page: www.pharmaresearchlibrary.com/ijctpr
More informationFormulation of Low Dose Medicines - Theory and Practice
Hashim Ahmed, Ph.D. and Navnit Shah, Ph.D. Pharmaceutical and Analytical R&D, Hoffmann-La Roche Inc., Nutley NJ Formulation of Low Dose Medicines - Theory and Practice Progress in pharmaceutical research
More informationInfluence of different grades and concentrations of hydroxypropyl methyl cellulose on the release of metformin hydrochloride
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationSolubility and Dissolution Rate Determination of Different Antiretroviral Drugs in Different ph Media Using UV Visible Spectrophotometer
ISSN: 973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 28, 5(S2), 1159-1164 Solubility and Dissolution Rate Determination of Different Antiretroviral Drugs in Different ph Media Using UV Visible
More information9. Gastroretentive beads (GRBs) 9.1. Preparation of GRBs
9. Gastroretentive beads (GRBs) 9.1. Preparation of GRBs Beads were prepared by ionotropic gelation method using sodium alginate and calcium chloride as per previously reported (Dhalleine et al., 2011;
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF IBUPROFEN 1 K.Vinay Kumar*, 1 V. Swetha Kruthika, 1 C.V.S
More informationInternational Journal of Medicine and Health Profession Research
Research Article ISSN: 2394 7403 International Journal of Medicine and Health Profession Research Journal home page: www.ijmhpr.com FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING SUSTAINED RELEASED
More informationCHAPTER - 5 DEVELOPMENT AND EVALUATION OF ALFUZOSIN ER TABLETS
55 CHAPTER - 5 DEVELOPMENT AND EVALUATION OF ALFUZOSIN ER TABLETS 5.1 MATERIALS AND EQUIPMENTS Table 5.1: List of materials used in research work Name of the Material Manufacturer Alfuzosin Hydrochloride
More informationEffect of Alkaline Excipients on The Release Profile of Gliclazide Extended Release Tablets
Effect of Alkaline Excipients on The Release Profile of Gliclazide Extended Release Tablets Monika Srivastav 1, B Prabhakar 1, Ashok Omray 2 1 School of Pharmacy & Technology Management, NMIMS University,
More informationJournal of Chemical and Pharmaceutical Research, 2014, 6(7): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(7):2356-2363 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Liquid chromatographic method development and
More informationFORMULATION AND EVALUATION OF FAST DISSOLVING CHLORTHALIDONE TABLETS
International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 1, Suppl 1, Nov.-Dec. 2009 Research Article FORMULATION AND EVALUATION OF FAST DISSOLVING CHLORTHALIDONE TABLETS RAGHAVENDRA RAO N.G
More informationCHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)
CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC A UV spectrophotometric method based on the measurement of absorbance at 276nm in phosphate buffer of p H 7.4 was used in the present study of the
More informationPlop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)
Page 1 of 7 Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest) Learning Objectives: Study the dissolution rate (how quickly the compound dissolves) of common OTC (over the
More informationFormulation and Evaluation of Ranitidine Hydrochloride Floating Tablets by Using Co-Processed Excipients
Human Journals Research Article July 2017 Vol.:9, Issue:4 All rights are reserved by APARNA KODRE et al. Formulation and Evaluation of Ranitidine Hydrochloride Floating Tablets by Using Co-Processed Excipients
More informationResearch Article Spectrophotometric Estimation of Didanosine in Bulk Drug and its Formulation
Research Article Spectrophotometric Estimation of Didanosine in Bulk Drug and its Formulation RN. Kane, PS. Bhokare*, CC. Nalawade, MS Sayyed and RD. Paliwal Department of Pharmaceutical Chemistry, Singhad
More informationMETHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS
CHAPTER 6 METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS School of Pharmaceutical Sciences, Vels University 106 METHOD DEVELOPMENT AND VALIDATION
More informationFormulation development and In-Vitro evaluation of floating tablets of Cefixime
48 Formulation development and In-Vitro evaluation of floating tablets of Cefixime B. Venkateswara Reddy Department of Pharmaceutics, St. Pauls College of Pharmacy, Hayathnagar, R.R. Dist, India basu.pharmacist@gmail.com
More informationFORMULATION, DEVELOPMENT AND CHARACTERIZATION OF ORAL DISINTEGRAING TABLET OF CIMITIDINE HCL
wjpmr, 2018,4(12), 233-237 SJIF Impact Factor: 4.639 Marabathuni et al. Research Article WORLD JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH ISSN 2455-3301 www.wjpmr.com WJPMR FORMULATION, DEVELOPMENT
More informationSPECIALIZED LABORATORY of pharmaceuticals manufacturing
SPECIALIZED LABORATORY of pharmaceuticals manufacturing Department of organic technology (111) Solid dosage forms testing: Dissolution test Supervisors: Laboratory location: S25b Introduction Ensuring
More informationFormulation and in-vitro evaluation of sustained release matrix tablets of gliclazide
Research Article S.Shanmugamet al. /BioMedRx 2013,1(4), Available online through http://jprsolutions.info Formulation and in-vitro evaluation of sustained release matrix tablets of gliclazide S.Shanmugam,
More informationDissolution Method Development and Validation of Paracetamol Aceclofenac Tablets
Research Article Dissolution Method Development and Validation of Paracetamol Aceclofenac Tablets Heena Farheen, T. Mamatha*, Zareena Yasmeen and Sharmila Sutradhar Department of Quality Assurance, Sultan-Ul-Uloom
More informationPreparation and Evaluation of Matrix Tablets Containing Ambroxol Hydrochloride
139 Research Article Preparation and Evaluation of Matrix Tablets Containing Ambroxol Hydrochloride Soma Vinisha*, Sajida Akhtari Begum, Nikhat Tabassum, Soma Anusha Department of pharmaceutical science,
More informationCHAPTER 7 SUMMARY AND CONCLUSIONS. constitutes the objective of many a research project in the field of pharmaceutical
CHAPTER 7 SUMMARY AND CONCLUSIONS Taste masking and development of palatable dosage forms of bitter drugs constitutes the objective of many a research project in the field of pharmaceutical technology.
More information104 Full Text Available On Research Article!!! Pharmaceutical Sciences. Received: ; Accepted:
International Journal of Institutional Pharmacy and Life Sciences 2(2): March-April 2012 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!! Received:
More informationMd.Khairul Alam et al / Journal of Pharmaceutical Science and Technology Vol. 3 (6), 2011,
STUDY OF DISSOLUTION IMPROVEMENT OF VARIOUS POORLY WATER SOLUBLE DRUGS BY SOLID DISPERSION MIXING WITH HPMC 6CPS AND PEG 6 Md. Khairul Alam 1 *, Reza-ul Jalil 2, Nazia Zaman 1, Md. SM Ashraful Islam 3
More informationFormulation and Evaluation of Immediate Release Tablets of Nevirapine Solid Dispersions
ARC Journal of Pharmaceutical Sciences (AJPS) Volume 4, Issue 3, 2018, PP 13-20 ISSN No.: 2455-1538 DOI: http://dx.doi.org/10.20431/2455-1538.0404003 www.arcjournals.org Formulation and Evaluation of Immediate
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE DEVELOPMENT OF VALIDATED UV SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF BETAXOLOL HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM SIDHARTH
More informationValidated First Order Derivative Spectroscopic Method for the determination of Stavudine in Bulk and Pharmaceutical Dosage Forms
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.3, No.1, pp 18-22, Jan-Mar 2011 Validated First Order Derivative Spectroscopic Method for the determination of Stavudine
More informationSimultaneous UV Spectrophotometric Method for the Estimation of Cefuroxime Axetil and Probenecid from Solid Dosage Forms
Research Paper www.ijpsonline.com Simultaneous UV Spectrophotometric Method for the Estimation of Cefuroxime Axetil and Probenecid from Solid Dosage Forms S. V. CHAUDHARI, ASHWINI KARNIK, ANURADHA ADHIKARY,
More informationINTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES
International Journal of Institutional Pharmacy and Life Sciences 6(2): March-April 2016 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!! Received:
More informationResearch Article. Simultaneous spectrophotometric estimation of Paracetamol and Aceclofenac by second order derivative method in combined dosage form
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2015, 7(6):512-517 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Simultaneous spectrophotometric estimation of Paracetamol
More informationResearch Article DEVELOPMENT AND CHARACTERIZATION OF ACECLOFENAC ENTERIC COATED TABLETS
International Journal of Research and Development in Pharmacy and Life Sciences Available online at http//www.ijrdpl.com October - November, 2015, Vol. 4, No.6, pp 1861-1866 ISSN (P): 2393-932X, ISSN (E):
More informationKing Saud University College of Pharmacy Department of Pharmaceutics. Biopharmaceutics PHT 414. Laboratory Assignments 2010 G 1431 H
King Saud University College of Pharmacy Department of Pharmaceutics Biopharmaceutics PHT 414 Laboratory Assignments 20 G 1431 H Department of Pharmaceutics Biopharmaceutics PHT -414 Laboratory Assignments
More informationUse of Roller Compaction in the Preparation of Verapamil Hydrochloride Extended Release Matrix Tablets Containing Hydrophilic Polymers
METHOCEL Application Data Premium Cellulose Ethers Use of Roller Compaction in the Preparation of Verapamil Hydrochloride Extended Release Matrix Tablets Containing Hydrophilic Polymers ABSTRACT SUMMARY
More informationCHAPTER.6 FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF ONDANSETRON HCl
CHAPTER.6 FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF ONDANSETRON HCl 6.1 Taste making of ondansetron HCl 6.1.1 Development and characterization of taste masked granules of ondansetron HCl
More informationThe Influence of Hydro-Alcoholic Media on Hypromellose Matrix Systems
METHOCEL Application Data Premium Cellulose Ethers The Influence of Hydro-Alcoholic Media on Hypromellose Matrix Systems OBJECTIVES The hydrophilic matrices (HM) continue to be a popular and widely used
More informationDesign and evaluation of a Sustained Release Gastroretentive Dosage form of Captopril
December - January, 2017; 6(2): 2535-2547 International Journal of Research and Development in Pharmacy & Life Science An International Open access peer reviewed journal ISSN (P): 2393-932X, ISSN (E):
More informationFormulation and Evaluation of Extended Release Tablets containing Metformin HCl
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 974-429 Vol.2, No.2, pp 132-1329, April-June 21 Formulation and Evaluation of Extended Release Tablets containing Metformin HCl Margret
More informationPRACTICAL APPROACH FOR THE ESTIMATION OF ALCOHOL DRUG RELEASE FROM THE SUSTAINED RELEASE DOSAGE FORMS OF VERAPAMIL HYDROCHLORIDE
295 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 4(6): November-December 2015 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY
More informationInternational Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.7, pp , 2016
International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 097-30, ISSN(Online): 255-9563 Vol.9, No.7, pp 399-06, 2016 Analytical Quality by Design Approach for Development of UV-Spectrophotometric
More informationPlop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)
Page 1 of 8 Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest) Learning Objectives: Study the dissolution rate (how quickly the compound dissolves) of common OTC (over the
More informationOndansetron hydrochloride (OSH) is an effective
dx.doi.org/10.14227/dt200413p34 In Vitro Dissolution Enhancement of Ondansetron by Solid Dispersion in Superdisintegrants e-mail: rkpharma26@yahoo.co.in Rajnikant M. Suthar 1, *, Narendra P. Chotai 1,
More informationFormulation & Evaluation of Mucoadhesive Drug Delivery System of Nifedipine
Formulation & Evaluation of Mucoadhesive Drug Delivery System of Nifedipine Vipul*, Ashish Singh Research and Development Department, Phyto Ingredients Biopharma Pvt. Ltd., Yamunanagar, Haryana, India
More informationScholars Research Library
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2010, 2(4): 509-519 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationPhysicochemical Characterization of Binary Ionic Polymer Blends: Polyvinyl Acetate Phthalate and Eudragit E PO
OPADRY Enteric Acrylic-Based Coating System Poster Reprint Physicochemical Characterization of Binary Ionic Polymer Blends: Polyvinyl Acetate Phthalate and Eudragit E PO PURPOSES Polymer complexes, such
More informationSpectrophotometric estimation and validation of hydrochlorothiazide in tablet dosage forms by using different solvents
Available online at www.derpharmachemica.com Scholars Research Library Der Pharma Chemica, 2012, 4 (1):10-14 (http://derpharmachemica.com/archive.html) ISSN 0975-413X CODEN (USA): PCHHAX Spectrophotometric
More informationInternational Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Research Article CODEN: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com FORMULATION AND EVALUATION OF GASTRORETENTIVE CIPROFLOXACIN
More informationJ Pharm Sci Bioscientific Res (4): ISSN NO
Development and Validation of Stability Indicating Analytical Method for Simultaneous Estimation of Perindopril and Potassium in Their Combined Marketed Dosage Form ABSTRACT: Gurjeet Kaur*, Nikhil Patel
More informationDEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR CLOPIDOGREL BISULFATE IN BULK AND FORMULATIONS
Int. J. Chem. Sci.: 10(1), 2012, 449-456 ISSN 0972-768X www.sadgurupublications.com DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR CLOPIDOGREL BISULFATE IN BULK AND FORMULATIONS PRAVIN CHOLKE
More informationAqueous Enteric Coating Application on Non-Banded Hard Gelatin Capsules
ACRYL-EZE Aqueous Acrylic Enteric System Application Data Aqueous Enteric Coating Application on Non-Banded Hard Gelatin Capsules OBJECTIVE To evaluate the application and performance of an aqueous enteric
More informationDissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form
Research Journal of Recent Sciences ISSN 2277-252 Dissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form Abstract Rele Rajan
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES
Research Article An In-Vitro Evaluation for the Effect of Β-Cyclodextrin and PVP-K 3 on Drug Release Pattern of Sertraline Hydrochloride Deepa Warrier 1, Aanna Zagade 1, Amir Shaikh 2*, Yogesh Pawar 2
More informationAsian Journal of Pharmaceutical Science & Technology FORMULATION AND EVALUATION OF ZOLMITRIPTAN RAPIMELTS
Asian Journal of Pharmaceutical Science & Technology e-issn: 2248 9185 www.ajpst.com Print ISSN: 2248 9177 FORMULATION AND EVALUATION OF ZOLMITRIPTAN RAPIMELTS T.Lavanya *, K.Navaneetha, P.Naga Haritha,
More informationof nm throughout the experimental work.
Difference Spectrophotometric Methods for Pioglitazone Hydrochloride and Metformin Hydrochloride K.Sujana, K.Abbulu, O.Bala Souri, B.Archana, M.Sindu, G.Swathi Rani Department of Pharmaceutical Analysis,
More informationResearch Article Development and Evaluation of Sustained Release Tablet of Betahistine Hydrochloride Using Ion Exchange Resin Tulsion T344
International Scholarly Research Network ISRN Pharmaceutics Volume 212, Article ID 438342, 5 pages doi:1.542/212/438342 Research Article Development and Evaluation of Sustained Release Tablet of Betahistine
More informationAnalytical method development and validation of carvedilol in bulk and tablet dosage form by using uv spectroscopic method as per ich guidelines
IJPAR Vol.6 Issue 2 April - June -2017 Journal Home page: ISSN:2320-2831 Research article Open Access Analytical method development and validation of carvedilol in bulk and tablet dosage form by using
More informationFormulation development and evaluation of glyburide beads for controlled release
Available online at wwwscholarsresearchlibrarycom Scholars Research Library Der Pharmacia Lettre, 213, 5 (3):17-177 (http://scholarsresearchlibrarycom/archivehtml) ISSN 975-571 USA CODEN: DPLEB4 Formulation
More informationPravin Kumar et al. / SGVU Journal of Pharmaceutical Research & Education, 2017, 2(1), Research Article
Research Article SGVU Journal of Pharmaceutical Research & Education Journal homepage: http://www.gyanvihar.org/researchjournals/ UV VISIBLE SPECTROSCOPIC METHOD DEVELOPMENT OF ETODOLAC FROM IT S TABLET
More informationValidated spectrophotometric determination of Fenofibrate in formulation
Available online at www.pelagiaresearchlibrary.com Der Pharmacia Sinica, 2010, 1 (1): 173-178 Validated spectrophotometric determination of Fenofibrate in formulation Krishna R. Gupta*, Sonali S. Askarkar,
More informationInt. J. Pharm. Sci. Rev. Res., 31(2), March April 2015; Article No. 26, Pages:
Research Article Y. Ganesh Kumar* 1, J. Sreekanth 2, D. Satyavati 3 1 Research Scholar, Faculty of Pharmaceutical Sciences, JNTU, Kukatpally, Hyderabad, Telangana, India. 2 Sr. General Manager, R&D Center,
More information3. Mechanistic analysis of drug release
3. 3.1 Introduction In the present chapter drug release characteristics from MCC based tablet cores coated with two different coating compositions for membrane controlled drug delivery were analyzed. Therefore
More informationZero And First Order Derivative Spectrophotometric Methods For Determination Of Dronedarone In Pharmaceutical Formulation
International Journal of PharmTech Research CDEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.1, pp 217-221, Jan-Mar 2013 Zero And First rder Derivative Spectrophotometric Methods For Determination f Dronedarone
More informationKetorolac tromethamine (KT)[1] is
RESEARCH ARTICLE Derivative and Simultaneous Equation Methods for the Determination of Fluorometholone and Ketorolac in Ophthalmic Preparations Chandaka Prasanna Kumar*, Bulusu Ravi Teja, Bhupathiraju
More information5. PREFORMULATION STUDY
5. PREFORMULATION STUDY Preformulation studies are the first step in the rational development of dosage form of a drug substance. The work was conducted by using Losartan Potassium as a model drug. The
More informationFORMULATION AND EVALUATION OF SOLID DISPERSIONS OF CARVEDILOL, A POORLY WATER SOLUBLE DRUG BY USING DIFFERENT POLYMERS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF SOLID DISPERSIONS OF CARVEDILOL, A POORLY WATER SOLUBLE DRUG
More informationSaudi Journal of Medical and Pharmaceutical Sciences
Saudi Journal of Medical and Pharmaceutical Sciences Scholars Middle East Publishers Dubai, United Arab Emirates Website: http://scholarsmepub.com/ ISSN 2413-4929 (Print) ISSN 2413-4910 (Online) Development
More informationInvestigation of Moisture-Activated Granulation of Hydrophilic Polymer Blends in Verapamil HCl Extended Release Matrices
METHOCEL Application Data Premium Cellulose Ethers Investigation of Moisture-Activated Granulation of Hydrophilic Polymer Blends in Verapamil HCl Extended Release Matrices ABSTRACT SUMMARY Hydrophilic
More informationDETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
CHAPTER 9 DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY CHAPTER 9 Determination of drug release during
More information